Press Releases

Celerion Announces Investment in ADME Suite of Services

Celerion, a clinical research organization (CRO) to the biopharmaceutical industry, has announced that it has made a significant investment in its ADME (Absorption, Distribution, Metabolism and Excretion) suite of services to meet continuously increasing demand to conduct these studies. This investment includes expanding laboratory space, adding new capabilities as well as a dedicated customer service team.

Rho Hires Global VP of Quality Assurance to Support International Expansion following Acquisition

Swiss CDMO expands capsule filling capabilities

Curebase and Blue Note Therapeutics Collaborate on Home-based Clinical Trial of Prescription Digital Therapeutics to Help People with Cancer Manage their Health

Curebase and Blue Note Therapeutics Collaborate on Home-based Clinical Trial of Prescription Digital Therapeutics to Help People with Cancer Manage their Health

Society of Toxicology Announced ScitoVation’s Senior Research Fellow, Jeffrey W. Fisher, PhD, Awarded 2022 SOT Arnold J. Lehman

ScitoVation has announced that Jeffrey W. Fisher, PhD has been awarded the 2022 Society of Toxicology (SOT) Arnold J. Lehman Award.

Rho Named A 2022 Health Care Leadership Award Winner by Triangle Business Journal

Rho Named A 2022 Health Care Leadership Award Winner by Triangle Business Journal March 15, 2022 - North Carolina-based Triangle Business Journal recently unveiled the winners of its 2022 class of Health Care Leadership Awards, naming Rho as one of this year’s honorees. The global, full-service contract research organization (CRO) was chosen from a pool of Triangle-area nominees that work in a number of health care settings, including major hospital systems, small physician groups, life sciences firms and nonprofit health charities. "The honorees of this year’s Health Care Leadership Awards are making a significant impact on the quality of health care in the Triangle region," said Jason Christie, market president and publisher of TBJ. "This year’s honorees really are heroes in our community. Triangle Business Journal is pleased to honor them.”

Curebase Rapidly Reaches Growth Milestone

Decentralized Clinical Trial Platform Provider Welcomes 100th Teammate

Tesis Biosciences Partners with Frontier Management to Provide Exclusive Pharmacogenetic Testing for Residents of Frontier’s Senior Living Facilities

Tesis Biosciences Partners with Frontier Management to Provide Exclusive Pharmacogenetic Testing for Residents of Frontier’s Senior Living Facilities

Enveda Biosciences Adds Drug Development Leaders to Scale Efforts and Accelerate Progress

Calyx EDC Selected for RWE Data Collection in Lengthy, Late Phase Trial

Leading pharmaceutical company trusts Calyx to meet accelerated timelines and support multi-year trials

VitaDAO and Molecule AG partner with Apollo Health Ventures to build the longevity biotech & Web3 ecosystem

Molecule has announced a tripartite partnership with Apollo Health Ventures and VitaDAO.

MicrobioSeq Releases PCR-based Microbial Antibiotic Resistance Gene Analysis Service

MicrobioSeq represents the microbial genomics division of CD Genomics, headquartered in New York, USA. CD Genomics MicrobioSeq is committed to delivering comprehensive microbial solutions to human health, agriculture, the environment, and industry by characterizing microbiomes and leveraging microorganisms. The company has recently announced the launch of PCR-based microbial antibiotic resistance gene analysis service to help researchers develop new antimicrobial medicines to address the worldwide threat of antibiotic resistance.

CD Genomics: Bioinformatics-Analysis Division Provides Genotyping Analysis Service for Studying Genetic Variations

CD ComputaBio Launches Homology Modeling Service for Drug Screening and Discovery

As a reliable computational biology service provider based in New York, CD ComputaBio has recently launched homology modeling service to help researchers deeply understand the structure-activity relationship of the target protein, and provide strong support for structure-based rational drug design, protein function research, and protein engineering research. Relying on its professional team and advanced technology, as well as high-quality products and services, CD ComputaBio has gained a solid reputation.

CD ComputaBio Releases Molecular Docking Service for Enzymology Research and Drug Design

CD ComputaBio, a reliable computational biology service provider located in New York, always hammers at researches and trials in order to provide customers with access to the latest software, technologies, and expertise at a competitive price and fast turnaround time. Recently, the product manager announced the launch of molecular docking service, which has a wide range of applications in the field of enzymology research and drug design.

Curebase and CoBTeK (team from Côte d’Azur) to Collaborate on a European Clinical Trial of Remote Tools Designed to Help Seniors Retain Autonomy

Curebase and CoBTeK (team from Côte d’Azur) to Collaborate on a European Clinical Trial of Remote Tools Designed to Help Seniors Retain Autonomy

Sinocompound announces commercial-scale production of QPhos ligand

Sinocompound has today announced production of the phosphine-based QPhos ligand in kilogram quantities for commercial use.

Rho Experts to Present at 5th Annual Gene Therapy for Rare Disorders Conference

Rho, a global full-service contract research organization (CRO), is sharing its drug development success and expertise in gene therapy research during the 5th Annual Gene Therapy for Rare Disorders Conference, taking place in Boston, Massachusetts from March 7-10. Rho’s Associate Director of Regulatory Strategy, Joseph Watson, Senior Director of Nonclinical Development, Brenda Faiola, and Research Scientist Kelsey Behrens will be giving a presentation titled, “Nonclinical Considerations to Enable a Successful Clinical Program.” The March 9 presentation at 2:00 p.m. will discuss key design and execution components, for nonclinical studies, necessary to enable clinical studies. The following items will be addressed: ü Considerations for gene therapy programs regarding animal models, dose selection, and delivery device compatibility ü Lessons Rho has learned in interacting with the FDA across various gene therapy programs ü Gene therapy approval examples that highlight key nonclinical considerations

Creative Biogene: A Premier Partner in the Exploration of Pathogenesis of Mitochondrial-Associated Diseases

Creative Biogene has become the premier partner to cooperate in the exploration of the pathogenesis of mitochondrial-associated diseases.

Pronalyse Launches Antibody Drug Conjugates (ADCs) Characterization Service for Drug Discovery

Pronalyse, a new division of Creative Proteomics, is an integrated CRO company with rich experience in providing drug development services for over 10 years. Creative Proteomics Pronalyse recently announced the launch of antibody-drug conjugates (ADCs) characterization service to ensure the safety and effectiveness of ADCs drugs.